A. Alvarez-Secord

646 total citations
27 papers, 467 citations indexed

About

A. Alvarez-Secord is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, A. Alvarez-Secord has authored 27 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Reproductive Medicine, 8 papers in Oncology and 8 papers in Obstetrics and Gynecology. Recurrent topics in A. Alvarez-Secord's work include Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Cancer Mechanisms and Therapy (5 papers). A. Alvarez-Secord is often cited by papers focused on Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Cancer Mechanisms and Therapy (5 papers). A. Alvarez-Secord collaborates with scholars based in United States and United Kingdom. A. Alvarez-Secord's co-authors include Brian Calingaert, Daniel L. Clarke‐Pearson, L. Havrilesky, John T. Soper, Vivian von Gruenigen, Warner K. Huh, Michael J. Miller, Amy P. Abernethy, Nicole D. Fleming and Victoria Bae‐Jump and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Gynecologic Oncology.

In The Last Decade

A. Alvarez-Secord

25 papers receiving 452 citations

Peers

Countries citing papers authored by A. Alvarez-Secord

Since Specialization

Citations

This map shows the geographic impact of A. Alvarez-Secord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Alvarez-Secord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Alvarez-Secord more than expected).

Fields of papers citing papers by A. Alvarez-Secord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Alvarez-Secord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Alvarez-Secord. The network helps show where A. Alvarez-Secord may publish in the future.

Co-authorship network of co-authors of A. Alvarez-Secord

This figure shows the co-authorship network connecting the top 25 collaborators of A. Alvarez-Secord. A scholar is included among the top collaborators of A. Alvarez-Secord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Alvarez-Secord. A. Alvarez-Secord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bevacizumab, TKI, or PARPi? A targeted approach using composite value-based endpoints and biomarkers to individualize care for platinum-sensitive recurrent ovarian cancer (PSROC) 2018 ·Gynecologic Oncology ·(unknown), A. Alvarez-Secord, Margaret Liang, Jessie Ehrisman, David E. Cohn, (unknown), (unknown)	1
2	Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study 2016 ·Gynecologic Oncology ·Peter G. Rose, James Java, Mark A. Morgan, A. Alvarez-Secord, Joshua P. Kesterson, Frederick B. Stehman, David Warshal, William T. Creasman, Parviz Hanjani, Robert Morris, Larry J. Copeland	7
3	Metformin reduces recurrence and improves survival in endometrial cancers 2013 ·Gynecologic Oncology ·Emily Ko, (unknown), Leslie H. Clark, Amanda Jackson, Jason M. Franasiak, L. Havrilesky, A. Alvarez-Secord, Paola A. Gehrig, Victoria Bae‐Jump	3
4	The impact of obesity and adjuvant chemotherapy regimens on women with ovarian granulosa cell tumors 2013 ·Gynecologic Oncology ·(unknown), (unknown), Janet Edwards, Britt Erickson, Warner K. Huh, A. Alvarez-Secord, Laura J. Havrilesky, (unknown), Neil S. Horowitz, Paola A. Gehrig	1
5	Redefining obesity, diabetes, and race in type I and type II endometrial cancers 2013 ·Gynecologic Oncology ·Emily Ko, (unknown), Leslie H. Clark, Laura J. Havrilesky, A. Alvarez-Secord, Paola A. Gehrig, Victoria Bae‐Jump	2
6	Cost-effectiveness of early palliative care intervention in recurrent plati- num-resistant ovarian cancer 2013 ·Gynecologic Oncology ·William J. Lowery, (unknown), Julie Barnett, Micael Lopez-Acevedo, (unknown), A. Alvarez-Secord, L. Havrilesky	1
7	Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer 2013 ·Gynecologic Oncology ·Rebecca A. Previs, (unknown), (unknown), Gloria Broadwater, (unknown), (unknown), (unknown), (unknown), A. Alvarez-Secord	1
8	Factors predictive of toxicity associated with bevacizumab and chemotherapy in recurrent ovarian cancer: A multi-institutional study 2012 ·Gynecologic Oncology ·John K. Chan, Warner K. Huh, C. McClung, A. Alvarez-Secord, Kathleen N. Moore, Rebecca A. Previs, (unknown), Katherine C. Fuh, Jocelyn Chapman, Todd Tillmanns	2
9	Downstream effects of first line bevacizumab (bev) on outcomes after recurrence in advanced ovarian cancer 2012 ·Gynecologic Oncology ·Erin Bishop, (unknown), Rebecca A. Previs, A. Alvarez-Secord, Kathleen N. Moore	1
10	A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors 2012 ·Cancer Chemotherapy and Pharmacology ·Gordana Vlahovic, Kellen L. Meadows, Hope E. Uronis, Michael A. Morse, Gerard C. Blobe, Richard F. Riedel, S. Yousuf Zafar, A. Alvarez-Secord, Jon P. Gockerman, Alexander Starodub, Neal Ready, Élizabeth Anderson, Johanna C. Bendell, Herbert I. Hurwitz	33
11	A practical prediction model for determining bevacizumab response and toxicity in the treatment of advanced ovarian and peritoneal cancers – An analysis of GOG 218 2012 ·Gynecologic Oncology ·John K. Chan, James Java, Bradley J. Monk, A. Alvarez-Secord, Daniel S. Kapp, Michael J. Birrer, Carol Aghajanian, Michael A. Bookman, Michael W. Kattan, Robert A. Burger	3
12	Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12months of prior platinum-based chemotherapy 2011 ·Gynecologic Oncology ·(unknown), (unknown), (unknown), Sachin M. Apte, (unknown), Jonathan Lancaster, Jesús González Bosquet, (unknown), L. Havrilesky, A. Alvarez-Secord	2
13	Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer 2011 ·Gynecologic Oncology ·(unknown), Evan R. Myers, A. Berchuck, A. Alvarez-Secord, (unknown), William J. Lowery, (unknown), L. Havrilesky	1
14	Surgical staging for endometrial cancer in the elderly: Is there a role for lymphadenectomy? 2011 ·Gynecologic Oncology ·William J. Lowery, (unknown), Eunjeong Ko, A. Alvarez-Secord, (unknown), L. Havrilesky	12
15	Indwelling Catheters for the Management of Refractory Malignant Ascites: A Systematic Literature Overview and Retrospective Chart Review 2009 ·Journal of Pain and Symptom Management ·Nicole D. Fleming, A. Alvarez-Secord, Vivian von Gruenigen, Michael J. Miller, Amy P. Abernethy	62
16	The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer 2007 ·Gynecologic Oncology ·A. Alvarez-Secord, L. Havrilesky, Victoria Bae‐Jump, (unknown), Brian Calingaert, Amy E. Bland, Teresa Rutledge, A. Berchuck, Daniel L. Clarke‐Pearson, (unknown)	100
17	Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience 2007 ·International Journal of Gynecological Cancer ·Warner K. Huh, J. Michael Straughn, Andrea Mariani, Karl C. Podratz, Laura J. Havrilesky, A. Alvarez-Secord, Michael A. Gold, D. Scott McMeekin, Susan C. Modesitt, Amy Cooper, Matthew A. Powell, David G. Mutch, Sukriti Nag, Ronald D. Alvarez, David E. Cohn	47
18	A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer 2006 ·Journal of Clinical Oncology ·Jason D. Wright, A. Alvarez-Secord, T. Michael Numnum, Rodney P. Rocconi, Matthew A. Powell, Andrew Berchuck, Ronald D. Alvarez, (unknown), Janet S. Rader, David G. Mutch	8
19	Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer 2004 ·Gynecologic Oncology ·(unknown), Charles A. Leath, Warner K. Huh, Brian Calingaert, (unknown), John T. Soper, A. Alvarez-Secord	57
20	A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma 2003 ·Cancer ·Ellen L. Jones, Thaddeus V. Samulski, Mark W. Dewhirst, A. Alvarez-Secord, Andrew Berchuck, Daniel L. Clarke‐Pearson, Laura J. Havrilesky, John T. Soper, Leonard R. Prosnitz	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact